2 Results for "

hepatoma H22

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "hepatoma H22" in MCE Product Catalog:

Cat. No.: HY-139815
CAS No.: 1314556-93-8
Target:  

HDAC

Research Areas:  

Cancer

ZYJ-34c is an orally active and potent histone deacetylase inhibitor (HDACi) with IC50s of 0.056 μM and 0.146 μM for HDAC6 and HDAC8, respectively. ZYJ-34c causes G1 phase arrest in low concentration. ZYJ-34c has antiproliferative activities. ZYJ-34c exhibits antitumor potency in MDA-MB-231 and HCT116 xenograft models and possesses antimetastatic potential in a mouse hepatoma-22 (H22) pulmonary metastasis model .
loading...
    loading...
Cat. No.: HY-P10832
CAS No.: 1228447-26-4
Research Areas:  

Cancer

ATWLPPRAANLLMAAS is a chimeric peptide with anti-angiogenic and potent anti-tumor effects. ATWLPPRAANLLMAAS can inhibit the proliferation, viability, migration, and invasion of human hepatocellular carcinoma cells, and induce apoptosis. .
loading...
    loading...